These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8757088)

  • 1. [Therapy of premenstrual syndrome with medroxyprogesterone acetate in various dosages].
    Szántó F; Hörömpöli C
    Orv Hetil; 1996 Jun; 137(24):1299-301. PubMed ID: 8757088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
    Freeman EW
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate monthly combination contraception to facilitate initiation of the depot medroxyprogesterone acetate contraceptive injection.
    Morroni C; Grams M; Tiezzi L; Westhoff C
    Contraception; 2004 Jul; 70(1):19-23. PubMed ID: 15208048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding contraceptive choices: lunelle monthly contraceptive injection.
    Shulman LP
    Int J Fertil Womens Med; 2000; 45(2):190-4. PubMed ID: 10831189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Same-day initiation of hormonal contraceptives.
    Scott T
    Am Fam Physician; 2009 Oct; 80(7):690. PubMed ID: 19817338
    [No Abstract]   [Full Text] [Related]  

  • 7. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM
    Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for drug therapy in premenstrual syndrome patients.
    Chihal HJ
    J Reprod Med; 1987 Jun; 32(6):449-52. PubMed ID: 2956417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
    Yonkers KA; Pearlstein T; Fayyad R; Gillespie JA
    J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of nomegestrol acetate in the treatment of menstruation disorders. Our experience in 56 cases].
    Persiani P; Radici E; Lombardi PA; Lombardi PL
    Minerva Ginecol; 1997 Apr; 49(4):181-5. PubMed ID: 9206771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depot-medroxyprogesterone acetate: an update.
    Bakry S; Merhi ZO; Scalise TJ; Mahmoud MS; Fadiel A; Naftolin F
    Arch Gynecol Obstet; 2008 Jul; 278(1):1-12. PubMed ID: 18470526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen.
    Coffee AL; Kuehl TJ; Willis S; Sulak PJ
    Am J Obstet Gynecol; 2006 Nov; 195(5):1311-9. PubMed ID: 16796986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New aspects of injectable contraception.
    Phillips OP
    Int J Fertil Womens Med; 2001; 46(1):31-6. PubMed ID: 11294618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monthly injection provides new contraceptive choice.
    FDA Consum; 2001; 35(1):5. PubMed ID: 11930928
    [No Abstract]   [Full Text] [Related]  

  • 15. Same-day administration of depot-medroxyprogesterone acetate injection: a retrospective chart review.
    Balkus J; Miller L
    Contraception; 2005 May; 71(5):395-8. PubMed ID: 15854642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of carbamazepine in premenstrual syndromes. A report on four cases.
    Gangdev PS; Joshi VS; Karnik PR; Dias L; Das S
    J Assoc Physicians India; 1991 May; 39(5):419-20. PubMed ID: 1960167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and acceptability of depo-medroxyprogesterone acetate injection. As a method of contraception in Saudi Arabia.
    Sobande AA; Al-Bar HM; Archibong EI; Sadek AA
    Saudi Med J; 2000 Apr; 21(4):348-51. PubMed ID: 11533816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of the premenstrual syndrome with a retroprogesterone (Duphaston)].
    Strecker JR
    Fortschr Med; 1980 Jan; 98(4):(145-7). PubMed ID: 7189174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and "add-back" therapy.
    Murray SC; Muse KN
    Fertil Steril; 1997 Feb; 67(2):390-3. PubMed ID: 9022620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An introductory clinical trial of three-monthly injectable contraceptive-depot medroxyprogesterone acetate].
    Shao Q; Jiang H; Fu W
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jan; 34(1):36-9. PubMed ID: 11263172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.